Prolonged intermittent high-volume hemofiltration as kidney replacement therapy in critically ill patients
| dc.article.number | 53 | |
| dc.catalogador | pva | |
| dc.contributor.author | Sepúlveda Palamara, Rodrigo Andrés | |
| dc.contributor.author | Huidobro Espinosa, Juan Pablo | |
| dc.contributor.author | Juanet Lecaros, Cristian Ignacio | |
| dc.contributor.author | Espinosa, María E. | |
| dc.contributor.author | González Muñoz, Loredana Elizabeth | |
| dc.contributor.author | Rot Cisternas, Ívica Damaris | |
| dc.contributor.author | Bello, Francisca | |
| dc.contributor.author | Salinas, Daniela | |
| dc.contributor.author | Hidalgo, Francisco | |
| dc.contributor.author | Delgado, Pablo | |
| dc.contributor.author | Roessler Barron, Eric | |
| dc.date.accessioned | 2025-07-07T20:31:11Z | |
| dc.date.available | 2025-07-07T20:31:11Z | |
| dc.date.issued | 2025 | |
| dc.date.updated | 2025-07-06T00:06:35Z | |
| dc.description.abstract | Background Prolonged and intermittent high-volume hemofiltration (HVHF) can be performed in extremely critical patients for hemodynamic support. In addition, it can serve as a kidney replacement therapy, given its large ultrafiltration volume. Our objective is to characterize the depuration properties of HVHF and hemodynamic tolerance. Methods This was a retrospective cohort study. All adult critical patients who received HVHF in a university hospital during 2021 were included. Demographic variables, past medical history, pre- and post-HVHF blood tests, and hemodynamic tolerance were evaluated. Results A total of 133 HVHF sessions were performed on 74 critical patients (age 61.1 ± 14.8 years, 43.2% women, and sequential organ failure assessment (SOFA) score 15.5 ± 3.8). All HVHF sessions were performed with prefilter replacement fluid, and 83.5% without anticoagulation. Time (QT) was 337 ± 86 min, with replacement flow rate (QR) at 81 ± 21 mL/kg/h. Hypotension occurred in 19.6% of the procedures at connection and 6.8% during therapy with no precipitating factor. Norepinephrine dose decreased ≥ 20% in 47.1% of the HVHF sessions. Single-pool urea Kt/V (spKt/V) was 0.52 ± 0.17. In HVHF of QT 6–8 h, spKt/V was 0.58 ± 0.17. Higher spKt/V was associated with higher QT and high QR. Post-HVHF sodium was significantly associated with sodium in the replacement fluid. Before HVHF, 18% had hyperkalemia (5.9 ± 1.1 mEq/L). Post-therapy kalemia was 4.8 ± 0.6 mEq/L. Post-HVHF potassium was associated with QR and ultrafiltration. Conclusions Prolonged and intermittent HVHF could serve as an alternative kidney replacement therapy in critically ill patients because it provides adequate control of the internal environment, allows withdrawal anticoagulation, favors patient mobility for procedures and treatments, and provides hemodynamic support. | |
| dc.fechaingreso.objetodigital | 2025-07-06 | |
| dc.format.extent | 7 páginas | |
| dc.fuente.origen | Biomed Central | |
| dc.identifier.citation | Renal Replacement Therapy. 2025 Jul 01;11(1):53 | |
| dc.identifier.doi | 10.1186/s41100-025-00644-5 | |
| dc.identifier.issn | 2059-1381 | |
| dc.identifier.uri | https://doi.org/10.1186/s41100-025-00644-5 | |
| dc.identifier.uri | https://repositorio.uc.cl/handle/11534/104871 | |
| dc.information.autoruc | Escuela de Medicina; Sepúlveda Palamara, Rodrigo Andrés; 0000-0002-9618-3686; 252768 | |
| dc.information.autoruc | Escuela de Medicina; Huidobro Espinosa, Juan Pablo; 0000-0002-5717-1017; 149948 | |
| dc.information.autoruc | Escuela de Medicina; Juanet Lecaros, Cristian Ignacio; S/I; 1052451 | |
| dc.information.autoruc | Escuela de Enfermería; González Muñoz, Loredana Elizabeth; S/I; 1071265 | |
| dc.information.autoruc | Escuela de Enfermería; Rot Cisternas, Ívica Damaris; S/I; 234370 | |
| dc.information.autoruc | Escuela de Medicina; Roessler Barron, Eric; S/I; 159750 | |
| dc.issue.numero | 1 | |
| dc.language.iso | en | |
| dc.nota.acceso | contenido completo | |
| dc.publisher | Springer Nature | |
| dc.revista | Renal Replacement Therapy | |
| dc.rights | acceso abierto | |
| dc.rights.holder | The Author(s) | |
| dc.rights.license | Attribution 4.0 International | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Hemofltration | |
| dc.subject | Hybrid renal replacement therapy | |
| dc.subject | Critical illness | |
| dc.subject | Acute kidney injury | |
| dc.subject.ddc | 610 | |
| dc.subject.dewey | Medicina y salud | es_ES |
| dc.subject.ods | 03 Good health and well-being | |
| dc.subject.odspa | 03 Salud y bienestar | |
| dc.title | Prolonged intermittent high-volume hemofiltration as kidney replacement therapy in critically ill patients | |
| dc.type | artículo | |
| dc.volumen | 11 | |
| sipa.codpersvinculados | 252768 | |
| sipa.codpersvinculados | 149948 | |
| sipa.codpersvinculados | 1052451 | |
| sipa.codpersvinculados | 1071265 | |
| sipa.codpersvinculados | 234370 | |
| sipa.codpersvinculados | 159750 |
